60.16
-0.14(-0.23%)
Currency In USD
| Previous Close | 60.3 |
| Open | 60.2 |
| Day High | 60.36 |
| Day Low | 58.25 |
| 52-Week High | 64.13 |
| 52-Week Low | 29.31 |
| Volume | 1.84M |
| Average Volume | 2.29M |
| Market Cap | 7.22B |
| PE | -9.56 |
| EPS | -6.29 |
| Moving Average 50 Days | 55.26 |
| Moving Average 200 Days | 42.78 |
| Change | -0.14 |
If you invested $1000 in Cytokinetics, Incorporated (CYTK) 10 years ago, it would be worth $4,895.04 as of November 08, 2025 at a share price of $60.16. Whereas If you bought $1000 worth of Cytokinetics, Incorporated (CYTK) shares 5 years ago, it would be worth $3,568.21 as of November 08, 2025 at a share price of $60.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytokinetics to Participate in November Investor Conferences
GlobeNewswire Inc.
Nov 04, 2025 9:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the following investor conferences in November: Stifel 2025 Hea
Cytokinetics Announces Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
GlobeNewswire Inc.
Oct 31, 2025 11:30 AM GMT
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced upcoming presentations, including three Late Breaking Science presentations related to MAPLE-HCM (Metoprolol vs Aficamten in Pa
Cytokinetics to Announce Third Quarter Results on November 5, 2025
GlobeNewswire Inc.
Oct 22, 2025 8:00 PM GMT
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 5, 2025 at 4:00 PM Eastern Time. Following the announcement, C